New 52 Week Low Today

NeuBase Therapeutics Inc NBSE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:40 AM EDT
6.03quote price arrow up+0.04 (+0.58%)
Volume
2,125,649
52 week range
5.42 - 12.89

...

Loading . . .
  • Open5.44
  • Day High6.09
  • Day Low5.42
  • Prev Close6.00
  • 52 Week High12.89
  • 52 Week High Date02/10/21
  • 52 Week Low5.42
  • 52 Week Low Date04/22/21

Key Stats

  • Market Cap139.89M
  • Shares Out23.18M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta-0.00
  • YTD % Change-14.45

KEY STATS

  • Open5.44
  • Day High6.09
  • Day Low5.42
  • Prev Close6.00
  • 52 Week High12.89
  • 52 Week High Date02/10/21
  • 52 Week Low5.42
  • 52 Week Low Date04/22/21
  • Market Cap139.89M
  • Shares Out23.18M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta-0.00
  • YTD % Change-14.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.81
  • P/E (TTM)-7.41
  • Fwd P/E (NTM)-6.04
  • EBITDA (MRQ)-17.747M
  • ROE (MRQ)-95.35%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From NeuBase Therapeutics Inc

There is no recent news for this security.

Profile

MORE
NeuBase Therapeutics, Inc. is a pre-clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The Company’s peptide-nucleic acid antisense oligonucleotide (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders. Its programs include NT0100, a PATrOL-enabled therapeutic program for systemic administration to...
Dietrich Stephan
President
William Mann Ph.D.
Chief Operating Officer
Sam Backenroth
Chief Financial Officer
Address
700 Technology Dr
Pittsburgh, PA
15219-3124
United States

Top Peers

SYMBOLLASTCHG%CHG
LYRA
Lyra Therapeutics Inc
11.66+0.89+8.26%
ENLV
Enlivex Therapeutics Ltd
10.40+0.21+2.04%
SIOX
Sio Gene Therapies Inc
2.41+0.02+0.62%
ATNM
Actinium Pharmaceuticals Inc
7.66+0.09+1.19%
CALA
Calithera Biosciences Inc
2.17+0.05+2.36%